INS and type 2 diabetes mellitus: lncRNA‐p3134, found deregulated in human patients and diabetic mice, seems to act as a new signaling molecule that maintains β‐cell mass and enhances insulin synthesis and secretion, and indeed it has been seen that lncRNA‐p3134 can contribute to reverse the insufficient insulin secretion in T2D.196